Command Palette

Search for a command to run...

Zenotech Laboratories Ltd.
50.95(+1.21%)
1W: -4.11%

Zenotech Laboratories Peer Comparison

Snapshot Summary

Zenotech Laboratories Ltd. is significantly underperforming its peers in terms of growth, profitability, and valuation metrics. While other companies in the sector show profitable operations and attractive growth rates, Zenotech struggles with negative growth and returns, making it a less favorable investment option.

  • Zenotech Laboratories has negative revenue growth and EPS, indicating underlying operational issues.
  • Cipla Ltd. and Dr. Reddy's Laboratories are standout performers with strong profitability and growth metrics.
  • Sun Pharmaceutical Industries appears overvalued despite its profitability due to a high PE ratio.
  • Zenotech is financially weak with a low ROE and negative profit margins.
  • Cipla Ltd.: Strong revenue and EPS growth, along with high ROE and low valuation metrics.
  • Dr. Reddy's Laboratories Ltd.: Solid profitability with high ROE and low valuation ratios, indicating strong performance.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
Zenotech Laboratories Ltd.₹56.39₹344.15Cr65.43-9.32%0.11
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.